Anti-VEGF Drugs in Age-Related Macular Degeneration: A Focus on Dosing Regimen-Related Safety and Efficacy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-VEGF Drugs in Age-Related Macular Degeneration: A Focus on Dosing Regimen-Related Safety and Efficacy
Authors
Keywords
-
Journal
DRUGS & AGING
Volume 40, Issue 11, Pages 991-1007
Publisher
Springer Science and Business Media LLC
Online
2023-10-21
DOI
10.1007/s40266-023-01068-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Pegcetacoplan With Progression of Incomplete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration
- (2022) Muneeswar Gupta Nittala et al. JAMA Ophthalmology
- Investigational drugs in clinical trials for macular degeneration
- (2022) Michael J Tolentino et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Faricimab: an investigational agent targeting the Tie-2/Angiopoietin pathway and VEGF-A for the treatment of retinal diseases
- (2021) Massimo Nicolò et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Identification of an intraocular microbiota
- (2021) Yuhua Deng et al. Cell Discovery
- An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials
- (2021) Wei Chiu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Age-Related Macular Degeneration
- (2021) Catherine J. Thomas et al. MEDICAL CLINICS OF NORTH AMERICA
- Unravelling the therapeutic potential of IL-33 for atrophic AMD
- (2021) Alison J. Clare et al. EYE
- Geographic Atrophy Incidence and Progression Following Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents for Age-Related Macular Degeneration
- (2021) Arshia Eshtiaghi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
- (2021) Rehan M Hussain et al. Drug Design Development and Therapy
- Progress of clinical therapies for dry age-related macular degeneration
- (2021) Rhianna Rubner et al. International Journal of Ophthalmology
- Visual Outcome and Treatment Frequency of Anti-VEGF Therapy Using the Treat-and-Extend and Treatment Cessation Regimen for Exudative Age-Related Macular Degeneration and Pachychoroid Neovasculopathy
- (2021) Takamasa Kinoshita et al. Clinical Ophthalmology
- Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2021) Nancy M. Holekamp et al. OPHTHALMOLOGY
- Penetratin modified lutein nanoemulsion in-situ gel for the treatment of age-related macular degeneration
- (2020) Ying Ge et al. Expert Opinion on Drug Delivery
- Risk factors for progression of age‐related macular degeneration
- (2020) Thomas J Heesterbeek et al. OPHTHALMIC AND PHYSIOLOGICAL OPTICS
- Retinal vasculitis and intraocular inflammation after intravitreal injection of brolucizumab
- (2020) Caroline R. Baumal et al. OPHTHALMOLOGY
- APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration
- (2020) Michael N. Cohen et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration
- (2020) Rong Sun et al. Expert Opinion on Drug Delivery
- Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update
- (2020) Fan-Li Lin et al. MOLECULAR THERAPY
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
- (2020) Arshad M. Khanani et al. JAMA Ophthalmology
- Targeting Angiopoietin in Retinal Vascular Diseases: A Literature Review and Summary of Clinical Trials Involving Faricimab
- (2020) Majid Khan et al. Cells
- C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration
- (2020) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Brolucizumab: A Newly Developed Anti-VEGF Molecule for the Treatment of Neovascular Age-Related Macular Degeneration
- (2020) Ramin Tadayoni et al. OPHTHALMOLOGICA
- Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab
- (2020) Jordi Monés et al. OPHTHALMOLOGY
- VEGF in Signaling and Disease: Beyond Discovery and Development
- (2019) Rajendra S. Apte et al. CELL
- Treatment of exudative age-related macular degeneration with aflibercept combined with pranoprofen eye drops or nutraceutical support with omega-3: A randomized trial
- (2019) Francesco Semeraro et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration
- (2019) James T. Handa et al. Nature Communications
- Title: Macular atrophy in neovascular age-related macular degeneration: A randomized clinical trial comparing ranibizumab and aflibercept (the RIVAL study)
- (2019) Mark C. Gillies et al. OPHTHALMOLOGY
- Age-Related Macular Degeneration Preferred Practice Pattern®
- (2019) Christina J. Flaxel et al. OPHTHALMOLOGY
- Faricimab: expanding horizon beyond VEGF
- (2019) Ashish Sharma et al. EYE
- Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration
- (2019) Nancy Holekamp et al. OPHTHALMOLOGY
- The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
- (2018) Monika Fleckenstein et al. OPHTHALMOLOGY
- The use of microperimetry in assessing visual function in age-related macular degeneration
- (2018) Nicola K. Cassels et al. SURVEY OF OPHTHALMOLOGY
- Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration
- (2018) Frank G. Holz et al. JAMA Ophthalmology
- Age-related macular degeneration
- (2018) Paul Mitchell et al. LANCET
- Indocyanine green molecular angiography of choroidal neovascularization
- (2018) Derrick J. Feenstra et al. EXPERIMENTAL EYE RESEARCH
- Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
- (2017) Paolo Lanzetta et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Aging retinal function is improved by near infrared light (670 nm) that is associated with corrected mitochondrial decline
- (2017) Chrishne Sivapathasuntharam et al. NEUROBIOLOGY OF AGING
- SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration
- (2017) Frank Enseleit et al. OPHTHALMOLOGICA
- OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY ASSESSMENT OF VASCULAR EFFECTS OCCURRING AFTER AFLIBERCEPT INTRAVITREAL INJECTIONS IN TREATMENT-NAIVE PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION
- (2017) Leonardo Mastropasqua et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB INJECTIONS FOR TYPE 3 NEOVASCULARIZATION
- (2017) Han Joo Cho et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration
- (2017) Brian L. Yaspan et al. Science Translational Medicine
- Early and intermediate age-related macular degeneration: update and clinical review
- (2017) Alfredo Garcia-Layana et al. Clinical Interventions in Aging
- Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre
- (2016) Pukhraj Rishi et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration
- (2016) U Schmidt-Erfurth et al. EYE
- Risk factors and biomarkers of age-related macular degeneration
- (2016) Nathan G. Lambert et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Differentiating drusen: Drusen and drusen-like appearances associated with ageing, age-related macular degeneration, inherited eye disease and other pathological processes
- (2016) Kamron N. Khan et al. PROGRESS IN RETINAL AND EYE RESEARCH
- A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants
- (2015) Lars G Fritsche et al. NATURE GENETICS
- Two-Year Outcomes of “Treat and Extend” Intravitreal Therapy for Neovascular Age-Related Macular Degeneration
- (2015) Jennifer J. Arnold et al. OPHTHALMOLOGY
- TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES
- (2015) K. Bailey Freund et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Age-Related Macular Degeneration: Genetics and Biology Coming Together
- (2014) Lars G. Fritsche et al. Annual Review of Genomics and Human Genetics
- Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
- (2014) Robert L Avery et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Systemic Vascular Safety of Ranibizumab for Age-Related Macular Degeneration
- (2014) Takashi Ueta et al. OPHTHALMOLOGY
- Age-Related Macular Degeneration
- (2014) Sang Jun Park et al. OPHTHALMOLOGY
- CLINICAL EVALUATION OF PAZOPANIB EYE DROPS IN HEALTHY SUBJECTS AND IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2014) Rishi Singh et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- The Relationship of Atherosclerosis to the 10-Year Cumulative Incidence of Age-related Macular Degeneration: The Beaver Dam Studies
- (2013) Ronald Klein et al. OPHTHALMOLOGY
- Optical Coherence Tomography–Based Observation of the Natural History of Drusenoid Lesion in Eyes with Dry Age-related Macular Degeneration
- (2013) Yanling Ouyang et al. OPHTHALMOLOGY
- Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
- (2013) Juan E. Grunwald et al. OPHTHALMOLOGY
- Causes of vision loss worldwide, 1990–2010: a systematic analysis
- (2013) Rupert R A Bourne et al. Lancet Global Health
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Ranibizumab for age-related macular degeneration
- (2012) Dilsher S Dhoot et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
- (2011) Michael Tolentino SURVEY OF OPHTHALMOLOGY
- Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
- (2011) Usha Chakravarthy et al. BMC Ophthalmology
- Imaging in Neovascular Age-Related Macular Degeneration
- (2011) Adam J. Gess et al. Seminars in Ophthalmology
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
- (2009) Geeta A. Lalwani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Age-Related Macular Degeneration
- (2008) Rama D. Jager et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now